Related Experiment Video

Updated: Jun 12, 2026

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

miRNAs as biomarkers in colorectal cancer diagnosis and prognosis

Jingfang Ju1

  • 1Translational Research Laboratory, Department of Pathology, Stony Brook University Medical Center, State University of New York-Stony Brook, Stony Brook, NY 11794-8691, USA. jiju@notes.cc.sunysb.edu

Bioanalysis
|June 15, 2010
PubMed

Insights

MicroRNAs (miRNAs) regulate gene expression and are implicated in cancer. This review explores their potential as colorectal cancer biomarkers, discussing current challenges and future directions.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Small non-coding microRNAs (miRNAs) regulate messenger RNA (mRNA) translation.
  • miRNAs play critical roles in cellular processes, influencing both oncogenesis and tumor suppression.
  • Dysregulation of miRNA expression is linked to various human diseases, particularly cancer.

Purpose of the Study:

  • To review recent discoveries on the potential of miRNAs as cancer biomarkers in colorectal cancer (CRC).
  • To highlight the dual role of miRNAs as potential oncogenes or tumor suppressors in CRC.
  • To discuss existing challenges and propose solutions for utilizing miRNAs in CRC diagnostics.

Main Methods:

  • Literature review of recent studies on miRNA biomarkers in colorectal cancer.
  • Analysis of miRNA regulatory mechanisms in cancer development.
  • Synthesis of current data on miRNA detection and clinical application.

Main Results:

  • miRNAs are emerging as promising biomarkers for early detection and prognosis of colorectal cancer.
  • Specific miRNA signatures are associated with different stages and subtypes of colorectal cancer.
  • The review consolidates evidence supporting miRNAs' diagnostic and therapeutic potential.

Conclusions:

  • miRNAs hold significant promise as non-invasive biomarkers for colorectal cancer.
  • Further research is needed to overcome challenges in standardization and clinical translation.
  • Harnessing miRNA potential could revolutionize colorectal cancer management.

More Related Videos

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening

Published on: October 26, 2017

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...